- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 15/12 - Gènes codant pour des protéines animales
Détention brevets de la classe C12N 15/12
Brevets de cette classe: 4703
Historique des publications depuis 10 ans
|
185
|
206
|
281
|
389
|
408
|
314
|
293
|
288
|
329
|
169
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Kyoto University | 2897 |
54 |
| The Regents of the University of California | 20694 |
52 |
| Regeneron Pharmaceuticals, Inc. | 4689 |
51 |
| University Health Network | 1059 |
46 |
| Spiber Inc. | 236 |
42 |
| Osaka University | 3268 |
40 |
| Universite de Montreal | 350 |
38 |
| Keio University | 1137 |
28 |
| The University of Tokyo | 4356 |
28 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 186 |
26 |
| The Trustees of the University of Pennsylvania | 4410 |
25 |
| Riken | 1715 |
25 |
| The Johns Hopkins University | 5869 |
24 |
| The University of British Columbia | 1537 |
23 |
| Takeda Pharmaceutical Company Limited | 2713 |
22 |
| Chugai Seiyaku Kabushiki Kaisha | 1415 |
22 |
| Xlifesc, Ltd. | 47 |
22 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3001 |
21 |
| Biocytogen Pharmaceuticals (Beijing) Co., Ltd | 226 |
21 |
| The General Hospital Corporation | 4855 |
20 |
| Autres propriétaires | 4073 |